Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This study investigated possible associations between selected polymorphisms in the serotonin receptor genes, 5-HT2A and 5-HT2C, with the presence of co-morbid depressive illness at baseline in a community based cohort of 158 patients with late onset patients with Alzheimer's disease (AD). An association was found between the presence of major depressive illness at baseline and both the 5-HT2A and 5-HT2C polymorphisms. Specifically, homozygous carriers of the 5-HT2A C102 allele were five times more likely to have major depressive illness than heterozygotes. In addition, homozygous or hemizygous carriers of the 5-HT2C Ser allele were 12 times more likely to have major depressive illness than homozygous or hemizygous carriers of the 5-HT2C Cys allele.

Original publication

DOI

10.1002/ajmg.b.10068

Type

Journal article

Journal

Am J Med Genet B Neuropsychiatr Genet

Publication Date

15/05/2003

Volume

119B

Pages

40 - 43

Keywords

Age of Onset, Aged, Aged, 80 and over, Alzheimer Disease, Cohort Studies, Comorbidity, Depression, Female, Genotype, Heterozygote, Homozygote, Humans, Male, Odds Ratio, Polymorphism, Genetic, Receptor, Serotonin, 5-HT2A, Receptor, Serotonin, 5-HT2C, Receptors, Serotonin, 5-HT2